Helema Pharma SRL
Helema Pharma reported total assets of 514,088 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Apr 2026).
The score of Helema Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +18 % Total assets +3 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Helema Pharma's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 30 Apr 2026
- Year ended 30 Sep 2024filed on 27 May 2025
- Year ended 30 Sep 2023filed on 19 Jun 2024
- Year ended 30 Sep 2022filed on 29 Apr 2023
- Year ended 30 Sep 2021filed on 28 Apr 2022
Helema Pharma's financial analysis
- Solvency40.6%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Helema Pharma
Helema Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0644.844.617
- VAT number
- BE0644844617
- Peppol
- Registered · 0208:0644844617 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Dec 2015
- Registered office
- 9620 Zottegem
- Latest accounts
- 2025 · filed on 30 Apr 2026
- Activity
- Activities of holding companies (NACE 64210)
Helema Pharma (SRL) has been based in Zottegem since 2015, active in: activities of holding companies. For 2025, it reports a net profit of 12,515 € and equity of 208,702 €; its revenue is not published. Its solvency stands at 40.6%, below the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Helema Pharma
Companies in the same business, of comparable size and area, outside its group.
- Renowvolt Activities of holding companies Tielt · balance sheet 514,406 €
- Farduci Activities of holding companies Antwerp · balance sheet 513,756 €
- SILK Activities of holding companies Ledegem · balance sheet 514,538 €
- C.E.N. - Invest Activities of holding companies Aalst · balance sheet 513,627 €
- Lotus Consulting Activities of holding companies Pelt · balance sheet 513,558 €
- Marla Activities of holding companies Sint-Laureins · balance sheet 514,625 €
- D2 Activities of holding companies Diepenbeek · balance sheet 514,724 €
- Pimarel Activities of holding companies Kuurne · balance sheet 513,207 €
Frequently asked questions about Helema Pharma
What is the revenue of Helema Pharma?
Helema Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Helema Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0644844617 for Helema Pharma, if the company is VAT-registered. Its company number (CBE) is 0644.844.617.
Where is the registered office of Helema Pharma?
According to the CBE register, the registered office of Helema Pharma is in 9620 Zottegem.
What is the equity of Helema Pharma?
At the close of the 2025 financial year, the equity of Helema Pharma amounts to 208,702 €, a solvency of 40.6% of total assets.
Who manages Helema Pharma?
The register lists 1 active mandates at Helema Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Helema Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →